Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure

ConclusionsThe use of milrinone compared with dobutamine in patients with ADHF-CS is associated with lower 30 day mortality and improved haemodynamics. These findings warrant further study in future randomized controlled trials.

https://onlinelibrary.wiley.com/doi/10.1002/ehf2.14379?af=R

Source: ESC Heart Failure - June 16, 2023 Category: Cardiology Authors: Eduard Rodenas ‐Alesina, Fernando Luis Scolari, Vicki N. Wang, Darshan H. Brahmbhatt, Vesna Mihajlovic, Nicole L. Fung, Madison Otsuki, Filio Billia, Christopher B. Overgaard, Adriana Luk Tags: Original Article Source Type: research